Go Back

Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions

Kiwamoto T., Kawasaki N., Paulson J. C., Bochner B. S.. (2012)

Pharmacology & Therapeutics, 135, 327


Pharmacology & Therapeutics, 135, 327


View Publication
This website uses cookies to ensure you get the best experience on our website. Learn more
Accept